The Euronanomed 3 network, in which the Fonds de recherche du Québec – Santé (FRQS) is a partner, is launching a multilateral joint transnational call for proposals to support research in the field of nanomedicine.
The aims of the call are:
To support translational research projects that combine innovative approaches in the field of nanomedicine and;
To encourage and enable transnational collaboration between public and private research groups from academia (research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital / public health, healthcare settings and other healthcare organisations) or research teams from industrial enterprises (all size).
Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:
a. Regenerative medicine
c. Targeted delivery systems
The projects should fall within Technology Readiness Levels (TRL) 3-6 and the projects should propose advancements for a maximum of two TRL levels during their lifetime.
Early-Career Scientist (Junior Researcher) – FRQS definition
Early career researchers (Junior 1 and Junior 2) are encouraged to submit an application as a Principal Investigator (the Junior status begins no more than six (6) years after obtaining a Ph.D. and lasts no more than eight (8) years).
Postdoctoral trainees cannot apply to this Competition as Investigators.
NEW : Nationale/Régionale Eligibility
All candidates eligible to receive funding from the FRQS wishing to apply to this program as a Principal Investigator must complete a form in FRQNet via the electronic portfolio under the available competition section. The deadlines for submitting an application follow those of the European call.
The information provided on the content of the call is indicative and may be subject to changes. Please refer to the official documents of the call on the European website.
For more information: EuroNanoMed website